CD8A and COVID-19: Lymphocytic response in COVID-19 has been subjected to intense research, and data point to suboptimal, excessive or otherwise inappropriate T-cell responses associated with severe disease, with high heterogeneity in gene expression of CD8 T cells in critical patients.16